UnitedHealth Group (NYSE:UNH) Announces Quarterly Earnings Results, Beats Expectations By $1.44 EPS

18 Jul 2026, 11:40 by Danessa Lincoln · The Markets Daily

UnitedHealth Group (NYSE:UNH – Get Free Report) issued its earnings results on Thursday. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44, FiscalAI reports. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same quarter in the prior year, the firm posted $4.08 earnings per share. The business’s revenue was up .4% on a year-over-year basis. UnitedHealth Group updated its FY 2026 guidance to 19.500-20.000 EPS.

Here are the key takeaways from UnitedHealth Group’s conference call:

UnitedHealth raised its full-year 2026 outlook, now guiding to adjusted EPS of $19.50 to $20.00 and higher operating earnings for both UnitedHealthcare and Optum Health after a stronger-than-expected second quarter.
Commercial medical cost trends remain elevated, with management saying they are running modestly above 11% and that margin recovery in the commercial business will take longer than previously expected.
Medicare Advantage performance improved, with lower-than-expected medical trend versus its original 2026 assumptions and better membership retention; the company now expects Medicare margins above 3% for the year.
Medicaid remains pressured as reimbursement rates continue to lag medical cost trends, even though second-quarter results were in line with expectations and management sees only early signs of improvement.
Optum businesses showed momentum, especially Optum Health, where care management, patient access, and AI-enabled workflow tools are improving experience and operations, while Optum Rx and Optum Insight continue to gain traction with transparency and AI-driven offerings.

UnitedHealth Group Trading Up 0.7%

Shares of UNH opened at $426.39 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.80. The firm has a market capitalization of $387.23 billion, a price-to-earnings ratio of 27.44, a PEG ratio of 1.58 and a beta of 0.62. The company has a 50-day moving average of $404.81 and a 200 day moving average of $342.28. UnitedHealth Group has a 1-year low of $234.60 and a 1-year high of $461.62.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were given a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a dividend yield of 2.2%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date was Monday, June 15th. UnitedHealth Group’s dividend payout ratio is 70.09%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of UnitedHealth Group stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the sale, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 0.28% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Revolve Wealth Partners LLC raised its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the last quarter. Brighton Jones LLC raised its holdings in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Strive Financial Group LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at $65,000. Garton & Associates Financial Advisors LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $112,000. Finally, Prosperity Bancshares Inc acquired a new stake in UnitedHealth Group during the fourth quarter worth about $114,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: UnitedHealth beat Q2 estimates on earnings and revenue, driven by improved margins and lower medical costs, and raised its 2026 profit outlook. UnitedHealth shares surge on strong earnings beat and guidance
Positive Sentiment: Morgan Stanley, Oppenheimer, UBS, RBC, and other firms lifted price targets after the results, signaling stronger Street confidence in the stock’s recovery. Analyst price target updates
Positive Sentiment: Management doubled the 2026 share repurchase target to at least $5 billion, which may help support EPS and investor returns. What’s Fueling UNH Stock’s Rally? A Bigger Buyback, Higher Guidance – And CEO Says Turnaround Is ‘Returning To Form’
Neutral Sentiment: Commentary around the earnings call says Medicare Advantage and Optum are improving, but commercial cost pressures could delay a full margin recovery. UnitedHealth Q2 Earnings Call Focuses on Reset and Durable Growth
Negative Sentiment: Some analysts remain cautious, with at least one downgrade noting that the turnaround still faces execution risk despite the stronger quarter. UnitedHealth Group Q2: The Real Test Begins Now (Downgrade)

Wall Street Analyst Weigh In

UNH has been the subject of several analyst reports. Erste Group Bank upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Monday, April 27th. Weiss Ratings upgraded shares of UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, July 10th. UBS Group increased their price objective on shares of UnitedHealth Group from $460.00 to $490.00 and gave the stock a “buy” rating in a research note on Friday. HSBC upped their target price on shares of UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a report on Monday, July 6th. Finally, TD Cowen boosted their price objective on UnitedHealth Group from $337.00 to $430.00 and gave the company a “hold” rating in a research report on Tuesday. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $447.29.

Read Our Latest Research Report on UnitedHealth Group

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.